These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 20484437)

  • 1. Sincalide-stimulated cholescintigraphy: what is the standard?
    Krishnamurthy GT; Krishnamurthy S
    J Nucl Med; 2010 Jun; 51(6):996; author reply 996-7. PubMed ID: 20484437
    [No Abstract]   [Full Text] [Related]  

  • 2. Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values.
    Ziessman HA; Tulchinsky M; Lavely WC; Gaughan JP; Allen TW; Maru A; Parkman HP; Maurer AH
    J Nucl Med; 2010 Feb; 51(2):277-81. PubMed ID: 20080900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sincalide cholescintigraphy--32 years later: evidence-based data on its clinical utility and infusion methodology.
    Ziessman HA
    Semin Nucl Med; 2012 Mar; 42(2):79-83. PubMed ID: 22293163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What value is normal for gallbladder ejection fraction, and how is it established?
    Krishnamurthy GT; Krishnamurthy S
    Radiology; 2003 Feb; 226(2):593-4; author reply 594-5. PubMed ID: 12563160
    [No Abstract]   [Full Text] [Related]  

  • 5. The SNM practice guideline on hepatobiliary scintigraphy.
    Tulchinsky M
    J Nucl Med; 2010 Dec; 51(12):1825. PubMed ID: 21098793
    [No Abstract]   [Full Text] [Related]  

  • 6. Normal values for sincalide cholescintigraphy: comparison of two methods.
    Ziessman HA; Muenz LR; Agarwal AK; ZaZa AA
    Radiology; 2001 Nov; 221(2):404-10. PubMed ID: 11687683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus report on standardization of sincalide cholescintigraphy.
    Ziessman HA; Tulchinsky M; Maurer A
    J Nucl Med; 2011 Aug; 52(8):16N. PubMed ID: 21810583
    [No Abstract]   [Full Text] [Related]  

  • 8. Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues.
    Ziessman HA
    J Nucl Med Technol; 2019 Sep; 47(3):210-212. PubMed ID: 31019045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin cholescintigraphy: methodology and normal values using a lactose-free fatty-meal food supplement.
    Ziessman HA; Jones DA; Muenz LR; Agarval AK
    J Nucl Med; 2003 Aug; 44(8):1263-6. PubMed ID: 12902416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of BD relied in great measure on gallbladder ejection fraction (GBEF) after sincalide stimulation on hepatobiliary scintigraphy.
    Tulchinsky M
    J Pediatr Surg; 2009 Oct; 44(10):2059; author reply 2059-60. PubMed ID: 19853777
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholecystokinin cholescintigraphy: victim of its own success?
    Ziessman HA
    J Nucl Med; 1999 Dec; 40(12):2038-42. PubMed ID: 10616884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculation of a gallbladder ejection fraction: advantage of continuous sincalide infusion over the three-minute infusion method.
    Ziessman HA; Fahey FH; Hixson DJ
    J Nucl Med; 1992 Apr; 33(4):537-41. PubMed ID: 1552338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gallbladder function obtained with regular CCK-8 and pharmacy-compounded CCK-8.
    Krishnamurthy S; Cerulli-Switzer J; Chapman N; Krishnamurthy GT
    J Nucl Med; 2003 Apr; 44(4):499-504. PubMed ID: 12679391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Characterization of basal hepatic bile...".
    Ziessman HA
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):920-2; author reply 922-3. PubMed ID: 15014905
    [No Abstract]   [Full Text] [Related]  

  • 15. Compounded versus proprietary sincalide for evaluation of gallbladder ejection fraction.
    Guarasci DT; Trinh LH; Baeumler GR; Bednarczyk EM
    Ann Pharmacother; 2004 Mar; 38(3):428-32. PubMed ID: 14755063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallbladder function: methods for measuring filling and emptying.
    Sarva RP; Shreiner DP; Van Thiel D; Yingvorapant N
    J Nucl Med; 1985 Feb; 26(2):140-4. PubMed ID: 3968578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the presence of other diseases exclude subjects as controls in studies of gallbladder response to cholecystokinin octapeptide (sincalide)? Scintigraphic results in patients with malignancies but no known gallbladder disease.
    Jacobson AF; Teefey SA
    Nucl Med Commun; 1996 Jun; 17(6):514-9. PubMed ID: 8822750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal Gallbladder Ejection Fraction Occurring Unexpectedly Obviates Need for Sincalide Stimulation.
    Hadi S; Tulchinsky M
    Clin Nucl Med; 2017 May; 42(5):394-396. PubMed ID: 28221193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional hepatobiliary disease: chronic acalculous gallbladder and chronic acalculous biliary disease.
    Ziessman HA
    Semin Nucl Med; 2006 Apr; 36(2):119-32. PubMed ID: 16517234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended application of 99mTc-mebrofenin cholescintigraphy with cholecystokinin in the evaluation of abdominal pain of hepatobiliary and gastrointestinal origin.
    Krishnamurthy GT; Krishnamurthy S
    Nucl Med Commun; 2010 May; 31(5):346-54. PubMed ID: 20147863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.